Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sino Bioenergy Corp Closes Acquisition Of Huizhou Biotech


Thursday, 20 Dec 2012 08:30am EST 

Sino Bioenergy Corp announced that it has closed a control stake in Huizhou Biotech firm in China. SFBE is purchasing a 55% stake in Huizhou Shi Ji Wu Feng Agricultural Biotechnology Co. Ltd., (HB) and has issued 130,520,000 restricted shares, valued at $0.10 a shares to close the USD13,520,000 acquisition. 

Latest Developments for Sino Bioenergy Corp

Company Quote

0.0124
-1.0E-4 -0.80%
24 Oct 2014